Science Explorer Back to mapMap
Institution · OncoRay

Most cited papers from OncoRay

What are the most cited papers from OncoRay?

The most cited paper from OncoRay is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "Spheroid-based drug screen: considerations and practical approach" (1,764) and "Multicellular tumor spheroids: An underestimated tool is catching up again" (1,699).

Showing 50 of 60 papers. Every paper with more than 138 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
2 Spheroid-based drug screen: considerations and practical approach Juergen Friedrich, Claudia Seidel, Reinhard Ebner et al. · Nature Protocols 12 Feb 2009 1,764
3 Multicellular tumor spheroids: An underestimated tool is catching up again Franziska Hirschhaeuser, Heike Menne, Claudia Dittfeld et al. · Journal of Biotechnology 26 Jan 2010 1,699
4 Radiation oncology in the era of precision medicine Michael A. Baumann, Mechthild Krause, Jens Overgaard et al. · Nature reviews. Cancer Review 18 Mar 2016 823
5 ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer Birgitte Vrou Offersen, Liesbeth Jorinne Boersma, Carine Kirkove et al. · Radiotherapy and Oncology Open access 2015 740
6 CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII Burak Koçak, Bettina Baeßler, Spyridon Bakas et al. · Insights into Imaging Open access 4 May 2023 464
7 Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge? Juergen Friedrich, Reinhard Ebner, Leoni A. Kunz‐Schughart · International Journal of Radiation Biology 2007 445
8 Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes Katrin Dietl, Kathrin Renner, Katja Dettmer et al. · The Journal of Immunology Open access 21 Dec 2009 402
9 A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms Monica Cojoc, Katrin Mäbert, Michael H. Muders et al. · Seminars in Cancer Biology 20 Jun 2014 394
10 Cancer stem cells: The root of tumor recurrence and metastases Claudia Peitzsch, Anna Tyutyunnykova, Klaus Pantel et al. · Seminars in Cancer Biology Mar 2017 389
11 Signalling via integrins: Implications for cell survival and anticancer strategies Stephanie Hehlgans, Michael Haase, Nils Cordes · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 5 Oct 2006 370
12 Focal adhesion signaling and therapy resistance in cancer Iris Eke, Nils Cordes · Seminars in Cancer Biology 10 Aug 2014 336
13 First clinical application of a prompt gamma based in vivo proton range verification system Christian Richter, G. Pausch, Steffen Barczyk et al. · Radiotherapy and Oncology Open access 13 Jan 2016 332
14 Human gastric cancer modelling using organoids Therese Seidlitz, Sebastian R. Merker, Alexander Rothe et al. · Gut Open access 27 Apr 2018 330
15 Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis Alex Zwanenburg · European Journal of Nuclear Medicine and Molecular Imaging 25 Jun 2019 313
16 Cancer Stem Cells and Radioresistance: DNA Repair and Beyond Alexander Schulz, Felix Benjamin Meyer, Anna Dubrovska et al. · Cancers Open access 21 Jun 2019 311
17 Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments Mechthild Krause, Anna Dubrovska, Annett Linge et al. · Advanced Drug Delivery Reviews ReviewOpen access 11 Feb 2016 311
18 METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII Burak Koçak et al. · Insights into Imaging Open access 16 Jan 2024 305
19 CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges Philipp Grosse‐Gehling, Christine A. Fargeas, Claudia Dittfeld et al. · The Journal of Pathology Open access 16 Aug 2012 301
20 Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation Marcel Naumann et al. · Nature Communications Open access 17 Jan 2018 297
21 Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma Dagmar Beier, Stefanie Röhrl, Deepu R. Pillai et al. · Cancer Research 15 Jul 2008 292
22 Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer Daniel Zips, Klaus Zöphel, Nasreddin Abolmaali et al. · Radiotherapy and Oncology Open access 27 Sep 2012 285
23 Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial Birgitte Vrou Offersen, Jan Alsner, Hanne Melgaard Nielsen et al. · Journal of Clinical Oncology 10 Sep 2020 274
24 BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance Ielizaveta Gorodetska, Iryna A. Kozeretska, Anna Dubrovska · Journal of Cancer Open access 2019 270
25 Expression of CD68 in Non‐Myeloid Cell Types Eva Gottfried, Leoni A. Kunz‐Schughart, Alexander N.R. Weber et al. · Scandinavian Journal of Immunology Open access 8 Apr 2008 265
26 The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia Thomas M. Ashton, Emmanouil Fokas, Leoni A. Kunz‐Schughart et al. · Nature Communications Open access 25 Jul 2016 260
27 Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments Xiaonan Zhang, Mårten Fryknäs, Emma Hernlund et al. · Nature Communications Open access 18 Feb 2014 255
28 Emerging targets in cancer management: role of the CXCL12/CXCR4 axis Anna Dubrovska, Monica Cojoc, Claudia Peitzsch et al. · OncoTargets and Therapy Open access Sep 2013 253
29 Assessing robustness of radiomic features by image perturbation Alex Zwanenburg, Stefan Leger, Linda Agolli et al. · Scientific Reports Open access 24 Jan 2019 252
30 ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1 Birgitte Vrou Offersen, Liesbeth Jorinne Boersma, Carine Kirkove et al. · Radiotherapy and Oncology 2016 247
31 Feasibility of proton FLASH effect tested by zebrafish embryo irradiation Elke Beyreuther, Michael Brand, Stefan Hans et al. · Radiotherapy and Oncology 29 Jun 2019 233
32 A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling Stefan Leger et al. · Scientific Reports Open access 10 Oct 2017 231
33 β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy Iris Eke, Yvonne Deuse, Stephanie Hehlgans et al. · Journal of Clinical Investigation Open access Mar 2012 221
34 Glycolytic metabolism and tumour response to fractionated irradiation Ulrike G. A. Sattler, Sandra S. Meyer, Verena Quennet et al. · Radiotherapy and Oncology 29 Dec 2009 214
35 Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice Verena Quennet, Ala Yaromina, Daniel Zips et al. · Radiotherapy and Oncology 15 Sep 2006 206
36 CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG) Panagiotis Balermpas et al. · International Journal of Cancer Open access 14 Jul 2015 206
37 Discovery of the cancer stem cell related determinants of radioresistance Claudia Peitzsch, Ina Kurth, Leoni A. Kunz‐Schughart et al. · Radiotherapy and Oncology Open access 3 Jul 2013 191
38 Range assessment in particle therapy based on promptγ-ray timing measurements Christian Golnik, Fernando Hueso-González, Andreas Müller et al. · Physics in Medicine and Biology Open access 26 Aug 2014 188
39 Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus Maarten L.F. Lambrecht et al. · Radiotherapy and Oncology Open access 17 May 2018 187
40 GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy Anna Mukha et al. · Theranostics Open access 2021 185
41 Dose-dependent biological damage of tumour cells by laser-accelerated proton beams Stephan Kraft et al. · New Journal of Physics Open access 9 Aug 2010 183
42 Human 6-Sulfo LacNAc-Expressing Dendritic Cells Are Principal Producers of Early Interleukin-12 and Are Controlled by Erythrocytes Knut Schäkel, Matthias von Kietzell, Anja Hänsel et al. · Immunity Open access Jun 2006 179
43 EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms Michael A. Baumann, Mechthild Krause, Ekkehard Dikomey et al. · Radiotherapy and Oncology 15 May 2007 178
44 Roadmap: proton therapy physics and biology Harald Paganetti et al. · Physics in Medicine and Biology Open access 23 Nov 2020 175
45 Dose rate dependence for different dosimeters and detectors: TLD, OSL, EBT films, and diamond detectors Leonhard Karsch, Elke Beyreuther, Trevor Burris-Mog et al. · Medical Physics 13 Apr 2012 173
46 MRI-guided Radiation Therapy: An Emerging Paradigm in Adaptive Radiation Oncology Ricardo Otazo, Philippe Lambin, Jean‐Philippe Pignol et al. · Radiology Open access 22 Dec 2020 171
47 Tumour irradiation in mice with a laser-accelerated proton beam Florian Kroll et al. · Nature Physics Open access Mar 2022 170
48 Does FLASH deplete Oxygen? Experimental Evaluation for Photons, Protons and Carbon Ions Jeannette Jansen, Jan Knoll, Elke Beyreuther et al. · arXiv (Cornell University) PreprintOpen access 25 Feb 2021 168
49 Joint EANM/SNMMI guideline on radiomics in nuclear medicine Mathieu Hatt, Aron K. Krizsan, Arman Rahmim et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access 3 Nov 2022 161
50 Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy” Juliane Rieber et al. · Lung Cancer Open access 30 Apr 2016 161

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.